Pulse Biosciences, Inc. — Operating Income by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/05d0189e-f4e4-400e-88b2-9c433a136156/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-76.9M | 2025-01-01 – 2025-12-31 | evidence 0001437749-26-004724 |
| FY 2024 | $-56.3M | 2024-01-01 – 2024-12-31 | evidence 0001437749-25-009932 |
| FY 2023 | $-43.6M | 2023-01-01 – 2023-12-31 | evidence 0001437749-24-009815 |
| FY 2022 | $-58.1M | 2022-01-01 – 2022-12-31 | evidence 0001437749-23-008846 |
| FY 2021 | $-63.0M | 2021-01-01 – 2021-12-31 | evidence 0001625101-22-000016 |
| FY 2020 | $-50.0M | 2020-01-01 – 2020-12-31 | evidence 0001625101-22-000016 |
| FY 2019 | $-48.0M | 2019-01-01 – 2019-12-31 | evidence 0001625101-22-000016 |
| FY 2018 | $-37.5M | 2018-01-01 – 2018-12-31 | evidence 0001625101-19-000008 |
| FY 2017 | $-25.6M | 2017-01-01 – 2017-12-31 | evidence 0001625101-18-000012 |
| FY 2016 | $-9.5M | 2016-01-01 – 2016-12-31 | evidence 0001625101-17-000011 |
| FY 2015 | $-4.5M | 2015-01-01 – 2015-12-31 | evidence 0001625101-17-000011 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).